JSPR Insider Trading
Insider Ownership Percentage: 2.70%
Insider Buying (Last 12 Months): $4,532,500.00
Insider Selling (Last 12 Months): $84,546.00
Jasper Therapeutics Insider Trading History Chart
This chart shows the insider buying and selling history at Jasper Therapeutics by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Jasper Therapeutics Share Price & Price History
Current Price: $5.51
Price Change: ▲ Price Increase of +0.17 (3.18%)
As of 01/17/2025 05:00 PM ET
Jasper Therapeutics Insider Trading History
Jasper Therapeutics Institutional Trading History
Data available starting January 2016
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and conditioning regimens for stem cell transplantation. In addition, it is also developing stem cell transplants for rare diseases such as sickle cell disease, fanconi anemia, chronic granulomatous diseases, and GATA2 MDS, and severe combined immunodeficiency. Jasper Therapeutics, Inc. is headquartered in Redwood City, California.
Read More on Jasper Therapeutics
Volume
720,615 shs
Average Volume
849,635 shs
Market Capitalization
$82.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.18
Who are the company insiders with the largest holdings of Jasper Therapeutics?
Jasper Therapeutics' top insider investors include:
- Velan Capital Investment Manag (Major Shareholder)
- Carlyle Group Inc (Major Shareholder)
- Holding Ltd Roche (Major Shareholder)
- Jeetinder Singh Mahal (Insider)
- Jeetinder Singh Mahal (COO)
- William Lis (Director)
- Thomas G Wiggans (Director)
- Anna Louise French (Director)
Learn More about top insider investors at Jasper Therapeutics.